| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 762.11B | 671.21B | 564.09B | 557.41B | 433.83B | 364.78B |
| Gross Profit | 111.16B | 72.42B | 75.73B | 65.28B | 60.37B | 60.17B |
| EBITDA | 57.41B | 30.12B | 45.22B | 31.24B | 32.45B | 34.32B |
| Net Income | 21.84B | 2.23B | 6.52B | 6.13B | 11.51B | 11.02B |
Balance Sheet | ||||||
| Total Assets | 679.69B | 596.56B | 480.27B | 475.58B | 421.29B | 361.27B |
| Cash, Cash Equivalents and Short-Term Investments | 43.80B | 70.62B | 27.49B | 19.00B | 15.93B | 20.46B |
| Total Debt | 334.59B | 290.17B | 137.12B | 179.48B | 152.16B | 134.69B |
| Total Liabilities | 436.52B | 382.04B | 235.98B | 264.59B | 231.79B | 198.38B |
| Stockholders Equity | 239.03B | 210.50B | 232.19B | 202.82B | 186.38B | 160.02B |
Cash Flow | ||||||
| Free Cash Flow | -39.21B | -71.82B | 33.29B | -10.81B | -14.57B | 18.28B |
| Operating Cash Flow | -9.85B | -50.63B | 48.24B | 7.59B | 3.54B | 38.20B |
| Investing Cash Flow | -49.75B | -21.74B | 8.80B | -16.49B | -18.81B | -17.39B |
| Financing Cash Flow | 62.25B | 114.93B | -50.01B | 9.80B | 9.39B | -19.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥572.84B | 19.60 | 9.28% | 1.30% | 5.50% | 27.32% | |
70 Outperform | ¥598.46B | 11.01 | ― | 3.15% | -0.88% | -25.64% | |
69 Neutral | ¥189.59B | 9.91 | 12.56% | 3.44% | 3.80% | 63.03% | |
69 Neutral | ¥22.36B | 2.45 | ― | 2.54% | 2.80% | 154.89% | |
67 Neutral | ¥66.97B | 20.57 | ― | 3.77% | -3.91% | -25.32% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | ¥314.02B | 10.01 | ― | 1.45% | 20.02% | ― |